674 Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving ¹ <sup>7</sup> <sup>7</sup> Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune responseAnusha Muralidhar, Lawrence Fong, Karen Law et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0
Abstract 4084: Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastasesAram Lyu, Lawrence Fong, Kiersten Tucker et al.|Cancer Research|2026Cited by 0
Abstract 2558: Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving177Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune responseAnusha Muralidhar, Lawrence Fong, Rahul R. Aggarwal et al.|Cancer Research|2026Cited by 0